The 2024-2025 flu season was one of the most severe in almost a decade, according to the Centers for Disease Control and ...

Sanofi ( ($SNY) ) just unveiled an update. In December 2025, Sanofi announced the completion of its acquisition of Vicebio Ltd, which enhances its ...

Sanofi completes acquisition of VicebioParis, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”).

After press reports flagged the possibility of an inactivated polio vaccine (IPV) shortage in India, Sanofi says it's ready to supply the nation with a newly approved shot. Thursday, after the company ...

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own. The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot ...

The U.S. FDA has approved an expanded indication for Sanofi (NASDAQ:SNY)’s quadrivalent meningococcal vaccine, MenQuadfi, now allowing its use in children as young as 6 weeks old. Previously approved ...

LONDON, Oct 24 (Reuters) - Sanofi (SASY.PA), opens new tab reported stronger than expected third-quarter profit on Friday, boosted by demand for blockbuster asthma drug Dupixent, even as the French ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. In a clinical trial, scientists are investigating whether a vaccine could treat patients with ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

Once upon a time, Sanofi Pasteur in Swiftwater, Monroe County, was the principal vaccine brand of Sanofi, the Paris-based international pharmaceutical company. However, in 2022 Sanofi underwent a ...